EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Changes in Gabapentinoid Use Among Danish Patients With Spinal Pain: A Comparison of Two Secondary Care Cohorts 2013–2014 and 2021–2022

Anders Hansen iD, Dorthe S Ziegler iD, Jan Hartvigsen iD, Christian V Skovsgaard iD, Stine Clausen iD, Casper Nim iD

European Journal of Pain · 2026

DOI: 10.1002/ejp.70305 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Pain, 2026. Verfasst von Anders Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Spinal Research, Spine Centre of Southern Denmark, University Hospital of Southern Denmark, Kolding, Denmark. Hauptthemen laut MEDLINE: Analgesics, Pregabalin, Gabapentin, Practice Patterns, Physicians'. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gabapentinoids (gabapentin and pregabalin) are increasingly prescribed for spinal pain despite limited evidence of benefit and recognised risks. Understanding which characteristics influence prescribing and how prescription use has evolved may inform safer and more evidence‐based practice.

Objectives

To compare determinants of gabapentinoid use and changes over time between two separate cohorts of patients referred to the Spine Centre of Southern Denmark.

Methods

Our study comprised two cohorts: the first, from 2013 to 2014 ( n = 16,732), and the second, from 2021 to 2022 ( n = 13,939). Redeemed gabapentinoid prescriptions were assessed within a 12‐month window (6 months before and after the spine centre index date) and linked with diagnostic, socioeconomic and patient‐reported information. Patients were categorised as continued users, initiators, discontinuers or non‐users using a ≥ 30 defined daily dose classification threshold to distinguish sporadic from more sustained dispensing. Multinomial logistic regression, incorporating demographic, socioeconomic and clinical covariates, identified characteristics associated with use.

Results

Gabapentinoid use more than doubled from Cohort 1 to Cohort 2, with continued users increasing from 2.4% to 6.6% and initiators increasing from 3.5% to 6.1%. Radiculopathy, higher disability and concurrent opioid or weak analgesic use showed the strongest positive associations with use across both cohorts.

Conclusions

Gabapentinoid use for patients with spinal pain attending secondary care in Denmark increased substantially across the decade, despite only modest differences in patient characteristics. Gabapentinoid use remained concentrated among patients with radiculopathy and concurrent analgesic use, underscoring continued reliance on pharmacological management. Significance Statement This study identifies a marked rise in gabapentinoid prescribing for spinal pain in secondary care and shows that the increase was only partly explained by differences in patient characteristics. The findings highlight continued use in patient groups where clinical benefit remains unproven, reinforcing the need for safer, more evidence‐based prescribing strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsPregabalinGabapentinPractice Patterns, Physicians'Back PainHumansDenmarkFemaleMaleMiddle AgedAdultSecondary Health CareAgedCohort Studies

Substanzen

AnalgesicsPregabalinGabapentin

Autor:innen und Institutionen

  • Medical Spinal Research, Spine Centre of Southern Denmark, University Hospital of Southern Denmark, Kolding, Denmark.
  • Department of Regional Health Research, University of Southern Denmark, Odense M, Denmark.
  • Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense M, Denmark.
  • Chiropractic Knowledge Hub, Odense, Denmark.
  • Danish Centre for Health Economics, Department of Public Health, University of Southern Denmark, Odense M, Denmark.

ORCID-Profile: Anders Hansen, Dorthe S Ziegler, Jan Hartvigsen, Christian V Skovsgaard, Stine Clausen, Casper Nim

Zitieren

APA

Hansen, A., Ziegler, D. S., Hartvigsen, J., Skovsgaard, C. V., Clausen, S., & Nim, C. (2026). Changes in Gabapentinoid Use Among Danish Patients With Spinal Pain: A Comparison of Two Secondary Care Cohorts 2013–2014 and 2021–2022. European Journal of Pain. https://doi.org/10.1002/ejp.70305

Vancouver

Hansen A, Ziegler DS, Hartvigsen J, Skovsgaard CV, Clausen S, Nim C. Changes in Gabapentinoid Use Among Danish Patients With Spinal Pain: A Comparison of Two Secondary Care Cohorts 2013–2014 and 2021–2022. European Journal of Pain. 2026. doi:10.1002/ejp.70305

BibTeX
@article{Hansen2026,
  author = {Hansen, Anders and Ziegler, Dorthe S and Hartvigsen, Jan and Skovsgaard, Christian V and Clausen, Stine and Nim, Casper},
  title = {Changes in Gabapentinoid Use Among Danish Patients With Spinal Pain: A Comparison of Two Secondary Care Cohorts 2013–2014 and 2021–2022},
  journal = {European Journal of Pain},
  year = {2026},
  doi = {10.1002/ejp.70305}
}
Kostenlos starten →